If you have trouble affording prescription drugs, some independent pharmacists say that so-called pharmacy middlemen are ...

Now, the Federal Trade Commission (FTC) is suing the largest PBMs for allegedly increasing the cost of insulin for patients with diabetes. These middlemen manage the drug benefits for virtually ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin ... three PBMs are the ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

By taking steps to hold middlemen ... Affordable Insulin Now Act moves towards the US Senate. Eisai has retreated from the optimistic view of sales growth for Alzheimer's disease drug Leqembi ...

Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug left to fill her prescription. Her neighborhood Fred Meyer pharmacy in ...

INSULIN LITIGATION DEEP-DIVE — As Congress ... in a New Jersey district court against the three major pharmacy middlemen — CVS Caremark, Express Scripts and OptumRx — and three insulin ...

According to researchers, the drug holds great promise for the tens of millions of insulin-requiring diabetics worldwide. Low blood glucose, or hypoglycemia, can be dangerous for diabetics.

Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...

“Your drug has a generic” that may cost less. In the case of insulin, if the generic is covered, it won’t cost less but chances are the plan will save money. And that can be a factor in what ...